What is it about?
Review about copper chelating agents experimentally and clinically evaluated for their ability to counteract copper homeostasis deregulation in Wilson's syndrome, neurological and neurodegenerative pathologies such as Alzheimer's and Parkinson's diseases, in idiopathic pulmonary fibrosis, in diabetes, and in several forms of cancer.
Featured Image
Photo by and machines on Unsplash
Read the Original
This page is a summary of: Current Biomedical Use of Copper Chelation Therapy, International Journal of Molecular Sciences, February 2020, MDPI AG,
DOI: 10.3390/ijms21031069.
You can read the full text:
Resources
NewsRX
Drugs and Therapies - Chelation Therapy; Studies from IRCCS Regina Elena National Cancer Institute in the Area of Chelation Therapy Reported
PubMed Central
Free PMC Article
Current biomedical use of copper chelation therapy
Publisher site
Effects of Copper Chelation on BRAFV600E Positive Colon Carcinoma Cells
Cancers (2019). 11 (5): 659. doi: 10.3390/cancers11050659.
Contributors
The following have contributed to this page
